141 related articles for article (PubMed ID: 2371923)
21. Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain.
Davenport KE; Houdi AA; Van Loon GR
Neurosci Lett; 1990 May; 113(1):40-6. PubMed ID: 2164174
[TBL] [Abstract][Full Text] [Related]
22. Restraint stress enhances morphine-induced analgesia in the rat without changing apparent affinity of receptor.
Appelbaum BD; Holtzman SG
Life Sci; 1985 Mar; 36(11):1069-74. PubMed ID: 2983165
[TBL] [Abstract][Full Text] [Related]
23. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
Adams JU; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
[TBL] [Abstract][Full Text] [Related]
24. Characterization of stress-induced potentiation of opioid effects in the rat.
Appelbaum BD; Holtzman SG
J Pharmacol Exp Ther; 1984 Dec; 231(3):555-65. PubMed ID: 6502514
[TBL] [Abstract][Full Text] [Related]
25. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
Pick CG; Nejat RJ; Pasternak GW
J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
[TBL] [Abstract][Full Text] [Related]
26. Alpha-fluoromethylhistidine decreases the Leu-enkephalinamide- and morphine-induced corticosterone response in rats.
Turon M; Fogel WA; Bugajski J
Pharmacology; 1991; 42(4):188-96. PubMed ID: 1712972
[TBL] [Abstract][Full Text] [Related]
27. The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency or morphine are additive.
Levesque D; Holtzman SG
Brain Res; 1993 Jul; 617(1):176-80. PubMed ID: 8374741
[TBL] [Abstract][Full Text] [Related]
28. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
Pavlovic ZW; Cooper ML; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
[TBL] [Abstract][Full Text] [Related]
29. Pentobarbital attenuates antinociception induced by i.c.v. morphine but not beta-endorphin in the mouse.
Tseng LF; Tang RR
Eur J Pharmacol; 1992 Apr; 214(2-3):175-80. PubMed ID: 1325355
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
31. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
[TBL] [Abstract][Full Text] [Related]
32. Stress-induced changes in the analgesic and thermic effects of opioid peptides in the rat.
Appelbaum BD; Holtzman SG
Brain Res; 1986 Jul; 377(2):330-6. PubMed ID: 3015351
[TBL] [Abstract][Full Text] [Related]
33. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
34. Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist.
Tive LA; Pick CG; Paul D; Roques BP; Gacel GA; Pasternak GW
Eur J Pharmacol; 1992 Jun; 216(2):249-55. PubMed ID: 1327812
[TBL] [Abstract][Full Text] [Related]
35. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
Sánchez-Blázquez P; Garzón J
Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
[TBL] [Abstract][Full Text] [Related]
37. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats.
Kiefel JM; Rossi GC; Bodnar RJ
Brain Res; 1993 Oct; 624(1-2):151-61. PubMed ID: 8252387
[TBL] [Abstract][Full Text] [Related]
38. Ketamine-induced potentiation of morphine analgesia in rat tail-flick test: role of opioid-, alpha2-adrenoceptors and ATP-sensitive potassium channels.
Campos AR; Santos FA; Rao VS
Biol Pharm Bull; 2006 Jan; 29(1):86-9. PubMed ID: 16394516
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat.
Ramarao P; Bhargava HN
Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162
[TBL] [Abstract][Full Text] [Related]
40. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
